Leuprolide Acetate 1-Month Depot for Central Precocious Puberty: Hormonal Suppression and Recovery

Methods. This prospective US multicenter trial of leuprolide acetate 1-month depot (7.5–15 mg) for central precocious puberty utilized an open-label treatment period, long-term follow-up, and adult callback. Forty-nine females <9 years old with Tanner breast stage ≥2 before 8 years and 6 males &l...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Neely, E. Kirk, Lee, Peter A., Bloch, Clifford A., Larsen, Lois, Yang, Di, Mattia-Goldberg, Cynthia, Chwalisz, Kristof
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2010
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3062984/
https://ncbi.nlm.nih.gov/pubmed/21437000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/398639
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky